Cargando…

ADC-1013, an agonistic CD40 antibody optimized for local immunotherapy of cancer

Detalles Bibliográficos
Autores principales:	Mangsbo, Sara M, Broos, Sissela, Gustafsson, Erika, Furebring, Christina, Veitonmäki, Niina, Dahlen, Eva, Norlen, Per, Lindstedt, Malin, Tötterman, Thomas, Ellmark, Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3991342/ http://dx.doi.org/10.1186/2051-1426-1-S1-P42

Ejemplares similares

Pre-clinical development of the human CD40 agonistic antibody ADC-1013
por: Norlén, Per, et al.
Publicado: (2015)

The human CD40 agonistic antibody ADC-1013 generates immune mediated anti-tumor effects in syngeneic tumor models in hCD40 transgenic mice
por: Mangsbo, Sara M, et al.
Publicado: (2014)

Kick-starting the cancer-immunity cycle by targeting CD40
por: Ellmark, P, et al.
Publicado: (2015)

Tumor-directed immunotherapy can generate tumor-specific T cell responses through localized co-stimulation
por: Ellmark, Peter, et al.
Publicado: (2016)

Synergistic effects of agonistic costimulatory antibodies adsorbed to amphiphilic poly(γ-glutamic acid) nanoparticles
por: Freiburghaus, Catja, et al.
Publicado: (2013)

Local immunotherapy based on agonistic CD40 antibodies effectively inhibits experimental bladder cancer
por: Sandin, Linda C, et al.
Publicado: (2014)

The human anti-CD40 agonist antibody mitazalimab (ADC-1013; JNJ-64457107) activates antigen-presenting cells, improves expansion of antigen-specific T cells, and enhances anti-tumor efficacy of a model cancer vaccine in vivo
por: Deronic, Adnan, et al.
Publicado: (2021)

Allergen-Specific Immunotherapy Alters the Frequency, as well as the FcR and CLR Expression Profiles of Human Dendritic Cell Subsets
por: Lundberg, Kristina, et al.
Publicado: (2016)

The CTLA-4 x OX40 bispecific antibody ATOR-1015 induces anti-tumor effects through tumor-directed immune activation
por: Kvarnhammar, Anne Månsson, et al.
Publicado: (2019)

Local CTLA4 blockade effectively restrains experimental pancreatic adenocarcinoma growth in vivo
por: Sandin, Linda C, et al.
Publicado: (2014)

Early Pharmacodynamic Changes Measured Using RNA Sequencing of Peripheral Blood from Patients in a Phase I Study with Mitazalimab, a Potent CD40 Agonistic Monoclonal Antibody
por: Andersson, Hampus, et al.
Publicado: (2023)

Adenovirus-mediated CD40L gene transfer increases Teffector/Tregulatory cell ratio and upregulates death receptors in metastatic melanoma patients
por: Schiza, A., et al.
Publicado: (2017)

Le synchrotron injecteur accélère 1013 ppi
Publicado: (1974)

macOS support essentials 10.13
por: Dreyer, Arek, et al.
Publicado: (2018)

1013 ejercicios y juegos aplicados al balonmano
por: Lasierra, Gerard
Publicado: (1992)

Development of OX40 agonists for canine cancer immunotherapy
por: Ruiz, Damien, et al.
Publicado: (2022)

Tumor endothelial cell up-regulation of IDO1 is an immunosuppressive feed-back mechanism that reduces the response to CD40-stimulating immunotherapy
por: Georganaki, Maria, et al.
Publicado: (2020)

OX40 Agonists and Combination Immunotherapy: Putting the Pedal to the Metal
por: Linch, Stefanie N., et al.
Publicado: (2015)

Next Generation CD40 Agonistic Antibodies for Cancer Immunotherapy
por: Salomon, Ran, et al.
Publicado: (2022)

The Bispecific Tumor Antigen-Conditional 4–1BB x 5T4 Agonist, ALG.APV-527, Mediates Strong T-Cell Activation and Potent Antitumor Activity in Preclinical Studies
por: Nelson, Michelle H., et al.
Publicado: (2023)

Sunitinib enhances the antitumor responses of agonistic CD40-antibody by reducing MDSCs and synergistically improving endothelial activation and T-cell recruitment
por: van Hooren, Luuk, et al.
Publicado: (2016)

Immunostimulatory AdCD40L gene therapy combined with low-dose cyclophosphamide in metastatic melanoma patients
por: Loskog, Angelica, et al.
Publicado: (2016)

Partita g-moll für Viola solo, nach BWV 1013
por: Bach, Johann Sebastian, 1685-1750
Publicado: (1992)

Can one 1013 proton burst melt the ps vacuum chamber?
por: Steinbach, C
Publicado: (1973)

HCV genotypes among 1013 Saudi nationals: a multicenter study
por: Al Traif, Ibrahim, et al.
Publicado: (2013)

1013. Electronic Assessment of Empiric Antibiotic Prescribing Using Diagnosis Codes
por: Dodds Ashley, Elizabeth, et al.
Publicado: (2019)

Introduction: Medicare Section 1013 and AHRQ's Effective Health Care Program
por: Chao, Schumarry H., et al.
Publicado: (2007)

1.013 ejercicios y juegos polideportivos : deportes de cooperación/oposición : baloncesto, balonmano, fútbol, hockey, rugby, voleibol, waterpolo /
por: Ticó Camí, Jordi
Publicado: (2000)

Local irradiation does not enhance the effect of immunostimulatory AdCD40L gene therapy combined with low dose cyclophosphamide in melanoma patients
por: Irenaeus, Sandra, et al.
Publicado: (2017)

The Combination Immunotherapy of TLR9 Agonist and OX40 Agonist via Intratumoural Injection for Hepatocellular Carcinoma
por: Zhou, Zhimei, et al.
Publicado: (2021)

Complete genome sequence of Leptotrichia buccalis type strain (C-1013-b(T))
por: Ivanova, Natalia, et al.
Publicado: (2009)

Adenoviral CD40 Ligand Immunotherapy in 32 Canine Malignant Melanomas–Long-Term Follow Up
por: Saellstrom, Sara, et al.
Publicado: (2021)

1013. Enhanced Oral Health Care Services for PLWHA - Midlands Region, South Carolina
por: Baello, Christina M, et al.
Publicado: (2020)

Mechanisms of ADC Toxicity and Strategies to Increase ADC Tolerability
por: Nguyen, Toan D., et al.
Publicado: (2023)

Agonist redirected checkpoint, PD1-Fc-OX40L, for cancer immunotherapy
por: Fromm, George, et al.
Publicado: (2018)

Those ADCs
Publicado: (1971)

Surgery for Gynecomastia in the Islamic Golden Age: Al-Tasrif of Al-Zahrawi (936–1013 AD)
por: Chavoushi, Seyed Hadi, et al.
Publicado: (2012)

A 40 MHz 11-Bit ENOB Delta Sigma ADC for Communication and Acquisition Systems
por: Fakhoury, Hussein, et al.
Publicado: (2022)

Novel ADCs and Strategies to Overcome Resistance to Anti-HER2 ADCs
por: Díaz-Rodríguez, Elena, et al.
Publicado: (2021)

Use of Bacteria- and Fungus-Binding Mesh in Negative Pressure Wound Therapy Provides Significant Granulation Tissue Without Tissue Ingrowth
por: Malmsjö, Malin, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_msj6e4dm9ugjp9qlqmtdsn01qp